Article Information
History
- November 15, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Jose Espejo Valle-Inclan1,2,*,
- Christina Stangl1,2,3,*,
- Anouk C. de Jong4,*,
- Lisanne F. van Dessel4,
- Markus J. van Roosmalen1,5,
- Jean C.A. Helmijr4,
- Ivo Renkens1,
- Sam de Blank1,
- Chris J. de Witte1,2,
- John W.M. Martens4,
- Maurice P.H.M. Jansen4,
- Martijn P. Lolkema4,$ and
- Wigard P. Kloosterman1,6,7,$
- 1Department of Genetics, Center for Molecular Medicine, University Medical Center Utrecht and Utrecht University, Utrecht, The Netherlands
- 2Oncode Institute
- 3Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands
- 4Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
- 5Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
- 6Cyclomics, Utrecht, The Netherlands
- 7Frame Cancer Therapeutics, Amsterdam, The Netherlands
- ↵$corresponding authors: wigardkloosterman{at}gmail.com; m.lolkema{at}erasmusmc.nl